Edmund Dunn

Principal Accounting Officer, Monte Rosa Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 4, 2026Sold 139 shares at $17.96 of Monte Rosa Therapeutics²
Mar 2, 2026Sold 536 shares at $17.50 of Monte Rosa Therapeutics³
Mar 2, 2026Exercised options 536 shares at $13.41 of Monte Rosa Therapeutics³
Feb 27, 2026Sold 25,164 shares at $18.10 of Monte Rosa Therapeutics³
Feb 27, 2026Exercised options 25,164 shares at $13.41 of Monte Rosa Therapeutics³
Jan 5, 2026Sold 1,039 shares at $15.17 of Monte Rosa Therapeutics⁴
Jun 3, 2025Sold 2,062 shares at $4.45 of Monte Rosa Therapeutics⁵
Jan 2, 2025Granted 11,850 shares of Monte Rosa Therapeutics⁶
Jul 5, 2024Sold 1,610 shares at $3.83 of Monte Rosa Therapeutics⁷
Jun 3, 2024Sold 1,207 shares at $4.04 of Monte Rosa Therapeutics⁸

The numbers on this page point here. Each one links to the record it came from.